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INTRODUCTION:
Thoracic epidural anesthesia is increasingly being used for
abdominal, major vascular and cardiothoracic & breast surgeries. The
objective of thoracic block is not solely to block noxious afferent
stimuli from the surgical site, but to impart a bilateral selective
thoracic sympathectomy. Provision of pain relief and sympatholysis of
such magnitude that allows patients to cough, breath deeply and
mobilize can contribute to enhanced postoperative outcomes such as
improved respiratory function, reduction in ileus , nausea and
vomiting.
Levobupivacaine and ropivacaine, the two new long-acting local
anesthetics, have been developed as an alternative to bupivacaine,
after the evidence of its severe toxicity. Both of these agents are pure
left-isomers and, due to their three-dimensional structure, seem to
have less toxic effects on the central nervous system (CNS) and on the
cardiovascular system
Ropivacaine is produced as pure “S” enantiomer withlower lipid
solubility, easier reversibility after inadvertent intravascular injection,
significant reduction in central nervous system toxicity, lesser motor
block and greater differentiation of sensory and motor block. Increasing
concentrations caused quicker onset, greater intensity, slower regression,
and longer duration of motor blockade. It is less lipophilic than
bupivacaine and is less likely to penetrate large myelinated motor fibers
resulting in a relatively reduced motor blockade. The reduced
lipophilicity is also associated with decreased potential for CNS and
cardiotoxicity. Thus, ropivacaine appears to be an important option for
regional anesthesia and for the management .
Levobupivacaine, the isolated S(-) enantiomer of bupivacaine, has
been shown to be less cardiotoxic than bupivacaine in preclinical
studies. Owing to the lower affinity of the S(-) isomer to the cardiac
sodium channels compared to the R(+) isomer, it is associated with less
cardiac side effects.
Both of these agents are pure left isomers, and based on their three-
dimensional structure; they have less toxicity to both the central nervous
system and the heart. The clinical profiles of levobupivacaine and
ropivacaine are similar to that of racemic bupivacaine, and the minimal
differences among the three agents are mainly related to the slightly
different anesthetic potency. They produce effects similar to other local
anesthetics via reversible inhibition of sodium ion influx in nerve fibers.
Hence, in this study to compare the effects oflevobupivacaine 0.5%
and ropivacaine 0.75% in thoracic epidural anesthesia for modified
radical mastectomy.
OBJECTIVES OF THE STUDY:
   The aim of the study is to  compare0.5%levobupivacaine and 0.75%
ropivacaine in thoracic epidural for modified radical mastectomy by
assessing
1. Time of onset
2. Duration,i.e, time interval between epidural drug bolus and first
epidural drug requirement.
3. Requirement of sedatives
4. Cardio toxicity i.e monitoring vital parameters,
electrocardiography, blood pressure, heart rate
5. Conversion of general anesthesia
6. Patient comfort i.e.visual pain analogue scale	
REVIEW OF LITERATURE:
Dr. ShalinaChandranet al.
It is important that new local anaesthetics that have lower
cardiotoxicity are adopted to ensure that regionaltechniques using large
amounts of local anaesthetics remain safe with minimal complications.
In the
present study using 0.75% ropivacaine and 0.5% bupivacaine epidurally,
there were no significant differences in the block parameters but
ropivacaine was associated with relatively longer duration of
postoperative analgesia.
VijetaMaheshwari et alIn the present study, we selected two
different dosages of local anesthetics – i.e., 0.5% levobupivacaine for
comparison against 0.75% ropivacaine for comparison. The reason for
this was a reported slower onset time for ropivacaine as compared to
levobupivacaine for the same dose. However, an enhanced dose of
ropivacaine (0.75%) has been shown to be comparable to a lower dose
of levobupivacaine (0.5%).[8]
Bajwaet al.,[10] who showed that epidural administration of 0.75%
ropivacaineepidurally shows a declining trend from around 75 min
postadministration interval. HR lowering effect of epidural ropivacaine
has been proven in animal studies 60 min after administration.[11] Thus,
it can be seen that both the drugs have a similar effect on HR which
varied under different conditions. As far as the present study is
concerned, both the drugs showed a similar effect and did not differ
significantly. For none of the drugs, any side effect in terms of
bradycardia was noticed.
Casati and Baciarello et al [12] reported that levobupivacaine 0.5%
produces an epidural block of similar onset,
quality, and duration as by the same volume of 0.5% bupivacaine with a
motor block deeper than thatproduced by 0.5% ropivacaine.
MATERIALS AND METHODS
SOURCE OF DATA:
 Patients undergoing modified radical mastectomy done under general
anesthesiaat Govt. KilpaukMedical College  and  Govt. Royapettah
Hospital, Chennai between February 2018 and july 2018will be assessed
for inclusion and exclusion criteria and will be included in the study
after obtaining written informed consent.
SAMPLE SIZE:60
Sample size was determined based on  the study ”a 	study	on		comparision	of	0.5%levobupivacaine	and	0.75%	ropivacaine	in	thoracic	epidural	for	modified	radical	mastectomy”
Description:
The formula for determining sample size is given as:
Where
n = Sample size
? = Population standard deviation
e = Margin of error
Z = The value for the given confidence interval
• The confidence level is estimated at 95%
• Standard deviation 58
• With a z value of 1.96
• The confidence interval or margin of error is estimated at +/-15
•  Assuming that 80 percent as power of the study, minimum sample
size required for the study was calculated to be 58.
In our study 60 subjects were chosen
(n=30 in GroupA , n= 30 in Group B)
STUDY DESIGN:
A prospective,Non –Randomized, double Arm, Single-
Blind, Controlled study
INCLUSION CRITERIA:1) Patients	undergoing	elective	modified	radical	mastectomy	under	thoracic	epidural	anesthesia.	2) Age	between	30	to	60	years	3) Females	4) ASA	class	1	and	2	
5) Patients	who	have	given	valid	informed	consent
EXCLUSION CRITERIA:
1) Patients not satisfying inclusion criteria.
2) Patients with an allergy or sensitivity to opioid group of drugs and
local anesthetics.
3) Patients with spinal deformities
4) Any contraindication to epidural anesthesia
5) Patients with neurological disorders
6) Impaired ability to communicate (e.g., confusion, poor hearing or
language barrier)
7) Patients who are unconscious or severely ill.
8) Pregnant patients.
9) Patients with Coagulation disorders.
MATERIALS:
1) Boyles apparatus
2) Laryngoscope with different blade sizes
3) Other airway gadgets used in case of difficult intubation
4) Endotracheal tubes
5) Drugs for administering general anesthesia
6) Epidural needle and catheter set
7) Glass syringe
8) Inj. Fentanyl , available as ampoules( one ampoule contains
2ml, each ml contains 50 mcg of Fentanyl)
9) Inj. Levobupivacaine available as vials in concentration of
0.5% ( one ampoule contains 10 ml ,  each ml contains 5mg)
10) Inj. Ropivacaineavailable as vials in concentration of 0.75%
( each vial contains 20 ml, each ml contains 7.5 mg )
11) Inj.midazolam1mg/ml total 5mg/5ml vial.
METHODOLOGY:
Patients in the above mentioned inclusion criteria selected will be
counselled about the risks and benefits involved in the study. After
getting consent, patients who are willing to be included in the study will
be enrolled and analyzed. A total of 60 patients will be included in the
study.Patients will be divided into two  groups of 30 in each based on
computerized random number into group A and group B.The patients in
Group A will be receiving 0.5% levobupivacaine ,the patients in Group
B will receive solution containing 0.75%  ropivacaine.The total volume
of drug in either group will be 15ml.
              This study is designed as a prospective, comparative study.
Patients will be  preoperatively evaluated, clinically examined and
proper investigations will be done prior to the assessment. Procedures
will be explained in detail and written consent will be obtained.The
procedure will be carried out in the theatre. Routine monitoring included
ECG, Pulse Oximetry, NIBP. Intravenous cannulation done with 18G
venflon.
Under sterile aseptic precautions, with patient in right lateral position
,midline or paramedian approach ,at the level of T3-T4 intervertebral
space, after subcutaneous infiltration of 2ml of 2% lignocaine, using
18G epidural needle, epidural space is identified by loss of resistance
technique, and 20 G catheter is threaded in via the needle. After ensuring
that blood or cerebrospinal fluid was not aspirated via catheter, 3ml of
2% lignocaine with adrenaline(1:2,00,000) dilution was administered via
it.
.The epidural drug administration is given 15 ml in both groups before
20 minutes of incision and sedation with inj.fentanyl 100mcg for both
groups and for maintenance drugs given according to the duration.
ASSESSMENT CRITERIA Group A Group B
Onset of action
Duration
Visual pain analogue scale
Heart rate
Blood pressure
Oxygen saturation
Respiratory rate
Conversion of general
anesthesia
Hypotension
Paresthesia
METHOD OF COLLECTION OF DATA
60 patients enrolled in the study who undergo elective modified radical
mastectomy under thoracic epidural anesthesia will be assessed
individually. The parameters mentioned above in the table will be
recorded at every 15 minutes throughout the surgery. The epidural top
up  dose  will  be  8ml  of  0.5%  levoBupivacaine  in  group  A  ,  8ml   of
0.75% ropivacaine in group B.
Duration of analgesia is calculated from the time of epidural bolus to the
time when first top up dose is required.
STATISTICAL ANALYSIS:
     Descriptive statistics will be done for all data and reported in terms of
mean values and percentages.Suitable statistical tests of comparison will
be done.
     Continuous variables will be analysed with the unpaired t test and
ANOVA single factor test.
     Categorical variables will be analysed with the Chi-Square Test and
Fisher Exact Test.
     Statistical significance will be taken as P<0.05.  The data will be
analysed using SPSS version 16 and Microsoft Excel 2007.
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STUDY CENTRE:  GOVT. KILPAUK MEDICAL COLLEGE &
GOVT ROYAPETTAH  HOSPITAL, CHENNAI
PATIENT’S NAME:
PATIENT’S AGE:
I.P NO            :
                        Patient may check (         ) these boxes
I confirm that I understood the purpose of the procedure for the above
study. I have the opportunity to ask question and all my questions and
doubts have been answered to my complete satisfaction
I understand that my participation in the study is voluntary and that I am
free to withdraw at any time without giving reason, without my legal
rights being affected.
I understand that the ethical committeemembers  and the regulatory
authorities will need not my permission to look at my health records,
both in respect of the current study and any further research that may be
conducted in relation to it, even if I withdraw from the study I agree to
this access. However, I understand that my identity will not be revealed
in any information released to third parties or published, unless as
required under the law.
I agree not to restrict the use of any data or results that arise from the
study.i agree to take part in the above study and to comply with the
instructions given during the study and faithfully co operate with the
study team and to immediately inform the study staff if I suffer from any
deterioration in my health or well being or any unexpected or unusual
symptoms.
I hereby consent to participate in this study.
I hereby give permission to undergo complete clinical examination and
diagnostic tests including hematological, biochemical, radiological tests.
Signature / thumb impression:
Patient’s name and address:                                          place:
date:
Signature of the investigator:
Study investigator’s name:                                             place:
date:
PARTICIPANTS” INFORMATION SHEET
Investigator : - Dr.R.BRINDHA
Name of the participant : -
Title”A 	 STUDY	ON	 	COMPARISION	OF	0.5%LEVOBUPIVACAINE	
AND	 0.75%	 ROPIVACAINE	 IN	 THORACIC	 EPIDURAL	 FOR	
MODIFIED	RADICAL	MASTECTOMY”
You are invited to take part in this research study. We have got
approval from the IEC. You are asked to participate because you
satisfy the eligibility criteria.
What is the purpose of this research?
In this study, efficacy of0.5% levobupivacaine and 0.75 %
of ropivacaine compared in thoracic epidural.so we can use this new
drug as a sole epidural and also to asses the benefits and
complications.In future both drugs will be used extensively because of
less complications and prolonged duration of action…
BENEFITS:
This study will help us in determining efficacy ,duration
,pospoperative analgesia, requirement of sedatives during thoracic
epidural and also to asses the cardiotoxicity and neurotoxicity…It also
helps in reducing the requirements of other opioidanalgesic drugs and
NSAIDS given via systemic route in the postoperative period which
causes many side effects like nausea, vomiting, itching, respiratory
depression.
DISCOMFORTS AND RISKS:
        Thoracic epiudural for modified radical mastectomy may
cause discomfort or anxiety during surgeries. Sometimes intercostal
paralysis causes respiratory depression.Local anesthesia toxicity may
also occur..
CONFIDENTIALITY:
Patients who participated in the study and their details will
be maintained confidentially and at any cost, those details will not be
let out
RIGHT TO WITHDRAW :
Patients  will not be forced to complete the study. At any cost, in such
circumstances the treatment  will not be compromised.
Date  : Signature of the investigator:
Place :
Signature/Thumb
impressionof  the
participant
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